The role of olfactory dysfunction in mild cognitive impairment and Alzheimer's disease: A meta-analysis

Jaime Bouhaben1, Alice Helena Delgado-Lima1, María Luisa Delgado-Losada1

  • 1Experimental Psychology, Cognitive Processes and Speech Therapy Department, Faculty of Psychology, Complutense University of Madrid, 28223 Pozuelo de Alarcon, Spain.

Abstract

Insights

Olfactory deficits, particularly in odor identification, are significant in mild cognitive impairment (MCI) and Alzheimer's disease (AD). A simple odor identification test can aid early AD detection in at-risk individuals.

Area of Science:

  • Neuroscience
  • Gerontology
  • Clinical Psychology

Background:

  • Olfactory dysfunction is increasingly recognized as an early indicator of neurodegenerative diseases.
  • Mild cognitive impairment (MCI) and Alzheimer's disease (AD) are associated with sensory deficits, including impaired sense of smell.
  • Understanding the specific olfactory deficits in MCI and AD is crucial for early diagnosis.

Purpose of the Study:

  • To conduct a meta-analysis investigating the association between olfactory deficits and mild cognitive impairment (MCI) and Alzheimer's disease (AD).
  • To quantify the magnitude of olfactory impairment in MCI and AD populations.
  • To explore the relationship between global cognitive status and olfactory deficits.

Main Methods:

  • A comprehensive meta-analysis was performed using data from identified articles.
  • Studies were assessed for methodological quality following PRISMA guidelines.
  • Hedges' g effect size was computed to determine standard mean differences and confidence intervals; moderator analysis was conducted.

Main Results:

  • Odor identification deficits showed larger effect sizes than odor threshold or discrimination in both MCI and AD samples.
  • Moderate effect sizes were observed in olfactory identification (OI) scores in MCI (k = 65).
  • Alzheimer's disease (AD) exhibited moderate to large heterogeneous effects in olfactory identification compared to MCI (k = 61).
  • Global cognitive status was positively related to olfactory identification impairment in both MCI and AD.

Conclusions:

  • Olfactory impairments, especially in odor identification, are notably present in MCI, mirroring deficits seen in AD.
  • Odor identification decline is the primary sensory deficit in MCI, similar to AD.
  • A simple odor identification test is recommended for evaluating individuals at risk for AD, serving as a practical early detection tool.

Related Concept Videos

Olfaction01:25

Olfaction

The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
44.3K
Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Physiology of Smell and Olfactory Pathway01:20

Physiology of Smell and Olfactory Pathway

Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
8.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
539